N2-[4-(4-ethylpiperazin-1-yl)-3-methoxy-phenyl]-N4-(1H-indazol-6-yl)-5-methyl-pyrimidine-2,4-diamine

ID: ALA5184634

Chembl Id: CHEMBL5184634

PubChem CID: 156704693

Max Phase: Preclinical

Molecular Formula: C25H30N8O

Molecular Weight: 458.57

Names and Identifiers

Canonical SMILES:  CCN1CCN(c2ccc(Nc3ncc(C)c(Nc4ccc5cn[nH]c5c4)n3)cc2OC)CC1

Standard InChI:  InChI=1S/C25H30N8O/c1-4-32-9-11-33(12-10-32)22-8-7-20(14-23(22)34-3)29-25-26-15-17(2)24(30-25)28-19-6-5-18-16-27-31-21(18)13-19/h5-8,13-16H,4,9-12H2,1-3H3,(H,27,31)(H2,26,28,29,30)

Standard InChI Key:  PQIKUMYNSRASMV-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5184634

   ---

2. Alternative Forms:

   

   ALA5184634

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 458.57

Molecular Weight (Monoisotopic): 458.2543

AlogP: 4.30

#Rotatable Bonds: 7

Polar Surface Area: 94.23

Molecular Species: NEUTRAL

HBA: 8

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 13.82

CX Basic pKa: 7.80

CX LogP: 4.19

CX LogD: 3.65

Aromatic Rings: 4

Heavy Atoms: 34

QED Weighted: 0.38

Np Likeness Score: -1.74

References

1. Chen X, Liu L, Liu P, Chen Y, Lin D, Yan H, Yan Q, Wang Y, Qiu Y, Fang B, Huang H, Qian J, Zhao Y, Du Z, Zhang Q, Li X, Zheng X, Liu Z..  (2022)  Discovery of Potent and Orally Bioavailable Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for the Treatment of Osteosarcoma.,  65  (7.0): [PMID:35239349] [10.1021/acs.jmedchem.1c01732]

Source

Source(1):

• Scientific Literature